SL
ARKG icon

Stevard LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Stevard LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,920
Closed -$257K – 56
2024
Q1 		$257K Hold
8,920
– – 0.23% 48
2023
Q4 		$293K Sell
8,920
-279
-3% -$7.59K 0.29% 41
2023
Q3 		$256K Sell
9,199
-443
-5% -$14.5K 0.26% 37
2023
Q2 		$329K Sell
9,642
-82
-0.8% -$2.58K 0.31% 36
2023
Q1 		$292K Hold
9,724
– – 0.27% 38
2022
Q4 		$275K Sell
9,724
-4,649
-32% -$148K 0.23% 41
2022
Q3 		$472K Buy
+14,373
New +$528K 0.44% 32
2022
Q1 		$777K Sell
16,909
-6,561
-28% -$313K 0.6% 23
2021
Q4 		$1.44M Sell
23,470
-6,348
-21% -$439K 1.02% 16
2021
Q3 		$2.23M Sell
29,818
-187
-0.6% -$15.7K 1.75% 12
2021
Q2 		$2.77M Buy
30,005
+31
+0.1% +$2.64K 2.14% 8
2021
Q1 		$2.66M Sell
29,974
-36,199
-55% -$3.59M 2.18% 7
2020
Q4 		$6.17M Buy
66,173
+2,711
+4% +$216K 2.09% 10
2020
Q3 		$4.04M Buy
63,462
+39,945
+170% +$2.34M 1.69% 13
2020
Q2 		$1.23M Buy
+23,517
New +$1.01M 0.63% 28

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Stevard LLC's ARKG Position: Q2 2024 in Review

Stevard LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,920 shares — an estimated $257K sold.

Stevard LLC first reported a position in ARKG in Q2 2020 and held it in 15 quarters. The position peaked at $6.17M in Q4 2020. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Stevard LLC reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Stevard LLC sold 8,920 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $257K.
  • Stevard LLC first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 15 quarters.
  • Stevard LLC's ARK Genomic Revolution ETF position peaked at $6.17M in Q4 2020.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Stevard LLC's 13F filing for Q2 2024, filed 9 Aug 2024.